Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FTC Review Of Express Scripts/Medco Merger Is First Integration Challenge

This article was originally published in The Pink Sheet Daily

Executive Summary

The proposed merger of two of the three major pharmacy benefit managers may have tough time clearing FTC; the agency has rejected other deals that would have left only two dominant players in a sector.

You may also be interested in...



Express Scripts/Medco Merger's Impact On Small Pharmacies Is Focus Of Hearing

Express Scripts CEO tells House Judiciary subcommittee that the companies would not be in favor of divesting their mail order and specialty pharmaceutical businesses.

Express Scripts/Medco Merger's Impact On Small Pharmacies Is Focus Of Hearing

Express Scripts CEO tells House Judiciary subcommittee that the companies would not be in favor of divesting their mail order and specialty pharmaceutical businesses.

Express Scripts/Medco Merger Faces Longer Odds After FTC's Second Request

Following the Federal Trade Commission’s second request for additional information about Express Scripts Inc.'s proposed acquisition of Medco Health Solutions Inc., it is now statistically likely that the deal will be blocked or subject to a divestiture.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS072549

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel